首页-XC杏彩-「领先的管理平台」
杏彩XC
-
杏彩XC药业产品热线：
4008 609 609
E-mail
OA
SUZHONG NETWORK COLLEGE
Contact
CN
ENG
Home
Company
About Us
Industry
History
News
Suzhong News
Industry News
Bidding News
Products
Pharmaceuticals
Medical equipment
R&D Center
R&D system
Research Trends
Brand Center
Enterprise Idea
Brand building
Group Party Building
Suzhong Elegance
Recruit
Idea
Policy
Job
Home
Company
About Us
Industry
History
Products
Pharmaceuticals
Medical equipment
Health products
R&D Center
R&D system
Research Trends
Brand Center
Enterprise Idea
Brand building
Group Party Building
Suzhong Elegance
home
Research and development center
Scientific Research
Research and development system
Scientific Research
Scientific Research
Policy news
The injection officially receives consistency evalsuation after the CDE Announcement.
April 15, 2019
Summary of Registered class 1 new drugs in China in the first quarter of 2019.
April 15, 2019
Analysis of current development status of biomedical industry in Jiangsu province.
April 15, 2019
Scientific research achievements
Phase 2 clinical study of class I drug SZMD4-mal has reviewed by clinical ethics.
April 15, 2019
Academic activity
Our institute has successfully held an academic seminar with Nanjing Gulou hospital on the research of Abelmoschus.
April 15, 2019
Company
About Us
Industry
History
新闻中心
杏彩XC新闻
行业动态
公示平台
Products
Pharmaceuticals
Medical equipment
Health products
R&D Center
R&D system
Research Trends
Brand Center
Enterprise Idea
Brand building
Group Party Building
Suzhong Elegance
人才中心
人才理念
政策福利
人才招聘
Thank you for your subscription
Email:
Telephones：4008 609 609
Address：No.1 Suzhong Road, Taizhou City, Jiangsu
SUZHONG WeChat
COPYRIGHT 2022 SUZHONG GROUP
苏ICP备89511499号-3
苏公网安备 32120402000295号
互联网药品信息服务资格证书（苏）-非经营性-2020-0163
杏彩XC
SUZHONG WeChat
苏公网安备 32120402000295号 互联网药品信息服务资格证书（苏）-非经营性-2020-0163